Plavix

Pharma

Earnings roundup: Bristol-Myers Squibb and Celgene

Bristol-Myers Squibb (NYSE:BMS) posted net income of $969 million in the third quarter of 2011 and is optimistic about its pipeline of drugs approaching or in phase 3 trials as they near approval.  It may have something to do with its blockbuster blood-thinning drug, Plavix, which has projected sales of $7 billion this year and […]

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.